TY - JOUR
T1 - Potential of Kidney Exchange Programs (KEPs) in Japan for Donor-Specific Antibody-Positive Kidney Transplants
T2 - A Questionnaire Survey on KEPs and a Multi-Institutional Study Conducting Virtual Cross-Matching Simulations
AU - Ito, Taihei
AU - Ito, Miki
AU - Aida, Naohiro
AU - Kurihara, Kei
AU - Terao, Akihiro
AU - Watarai, Yoshihiko
AU - Saito, Mitsuru
AU - Kaku, Keizo
AU - Ishii, Daisuke
AU - Sekiguchi, Satoshi
AU - Yoneda, Tatsuo
AU - Unagami, Kohei
AU - Tasaki, Masayuki
AU - Iwamoto, Hitoshi
AU - Araki, Motoo
AU - Takahashi, Kazuhiro
AU - Yamanaka, Kazuaki
AU - Sugimoto, Mikio
AU - Nishikawa, Kouhei
AU - Seto, Chikashi
AU - Muramatsu, Masaki
AU - Asai, Toshihiro
AU - Iwami, Daiki
AU - Yamada, Yasutoshi
AU - Yamanaga, Shigeyoshi
AU - Komatsu, Tomonori
AU - Miura, Masayoshi
AU - Nohara, Takahiro
AU - Maruyama, Michihiro
AU - Miyauchi, Yuki
AU - Tanaka, Toshiaki
AU - Nakamura, Michio
AU - Hotta, Kiyohiko
AU - Kenmochi, Takashi
N1 - Publisher Copyright:
© 2025 by the authors.
PY - 2025/9
Y1 - 2025/9
N2 - Objectives: To clarify the need for a kidney exchange program (KEP) in Japan by conducting a questionnaire survey on KEPs and simulated KEPs by virtual cross-matching based on past cases of transplantation avoidance. Methods: In addition to the content regarding KEPs, an electronic survey was conducted to investigate the number of cases of kidney transplant abandonment due to “immunological” reasons over the past 10 years (2012–2021). Virtual cross-matching was conducted to simulate the feasibility of avoiding immunological risks and enabling kidney transplantation in patients who were previously unable to undergo the procedure. Results: The survey received responses from 107 facilities (response rate: 81.7%). In response to the question about the necessity of a KEP in Japan, 71 facilities (66.4%) indicated that KEPs are necessary. In addition, 251 living-donor kidney transplants were abandoned for “immunological” reasons over the past decade (2012–2021). Among the 80 pairs for which detailed information was available, virtual cross-matching simulations showed that 37/80 pairs (46.3%) were donor-specific antibody (DSA)-negative for blood type-matched combinations, and 41/80 pairs (51.3%) were DSA-negative for blood type-incompatible transplants. Conclusions: The need for a KEP in Japan and its potential usefulness were demonstrated.
AB - Objectives: To clarify the need for a kidney exchange program (KEP) in Japan by conducting a questionnaire survey on KEPs and simulated KEPs by virtual cross-matching based on past cases of transplantation avoidance. Methods: In addition to the content regarding KEPs, an electronic survey was conducted to investigate the number of cases of kidney transplant abandonment due to “immunological” reasons over the past 10 years (2012–2021). Virtual cross-matching was conducted to simulate the feasibility of avoiding immunological risks and enabling kidney transplantation in patients who were previously unable to undergo the procedure. Results: The survey received responses from 107 facilities (response rate: 81.7%). In response to the question about the necessity of a KEP in Japan, 71 facilities (66.4%) indicated that KEPs are necessary. In addition, 251 living-donor kidney transplants were abandoned for “immunological” reasons over the past decade (2012–2021). Among the 80 pairs for which detailed information was available, virtual cross-matching simulations showed that 37/80 pairs (46.3%) were donor-specific antibody (DSA)-negative for blood type-matched combinations, and 41/80 pairs (51.3%) were DSA-negative for blood type-incompatible transplants. Conclusions: The need for a KEP in Japan and its potential usefulness were demonstrated.
KW - donor-specific antibodies
KW - kidney exchange program
KW - kidney transplantation
KW - virtual cross-matching
UR - https://www.scopus.com/pages/publications/105015750617
UR - https://www.scopus.com/pages/publications/105015750617#tab=citedBy
U2 - 10.3390/jcm14176122
DO - 10.3390/jcm14176122
M3 - Article
AN - SCOPUS:105015750617
SN - 2077-0383
VL - 14
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 17
M1 - 6122
ER -